The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 334:668 March 7, 1996 Number 10
NextNext

Polycystic Ovary Syndrome

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
To the Editor: Franks (Sept. 28 issue)1 cites a prevalence of hyperprolactinemia of up to 30 percent in women with polycystic ovaries, yet he does not address the treatment of women with the polycystic ovary syndrome and hyperprolactinemia. Carefully controlled studies, in which multiple blood samples were used to eliminate the effect of stress on prolactin levels, have demonstrated that the frequency of hyperprolactinemia in women with the polycystic ovary syndrome is similar to that in the general population.2,3 These and other findings4 challenge the commonly held belief that the polycystic ovary syndrome and hyperprolactinemia are associated conditions. Therefore, the . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.